Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

The Radiation Oncology-Biology Integration Network (ROBIN) Centers funding opportunity is administered by the National Institutes of Health (NIH), specifically through the National Cancer Institute (NCI), which operates under the U.S. Department of Health and Human Services. NIH is the primary federal agency responsible for conducting and supporting medical research, and NCI leads national efforts in cancer research and training. Through this opportunity, NIH continues its investment in collaborative, translational oncology research infrastructure that integrates biological science with radiation oncology practice. The purpose of this funding opportunity is to support a national network of research centers focused on understanding the biological mechanisms underlying cancer patients’ responses to radiation therapy. The ROBIN initiative emphasizes hypothesis-driven, translational research that explores how tumors and normal tissues evolve during radiation treatment. The program is designed to generate foundational insights that can improve radiation-based therapies and identify opportunities to combine radiation with other treatment modalities such as pharmaceuticals or targeted therapies. Funding will support multidisciplinary, longitudinal studies conducted across participating centers. These studies involve the systematic collection and analysis of biospecimens and multimodal data from patients before, during, and after receiving standard-of-care radiation therapy. The scope of work includes investigating treatment response, resistance mechanisms, and toxicity, as well as identifying dynamic biological targets that may change over the course of therapy. The program also supports the integration of diverse expertise, including clinical oncology, biology, imaging, dosimetry, omics, biospecimen science, and data science. Eligibility for this opportunity is broad and includes a wide range of applicant organizations. Eligible entities include public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, small and large businesses, state and local governments, tribal governments, and other entities such as faith-based or community organizations. Federal agencies and non-domestic (foreign) institutions are also eligible, reflecting the program’s emphasis on collaboration and global scientific engagement. This inclusivity supports the development of a robust and diverse research network. The application process will be conducted through standard NIH submission mechanisms, typically requiring applicants to prepare and submit a full proposal that includes detailed research plans, biospecimen collection protocols, data management strategies, and collaboration frameworks. Applications are expected to undergo a rigorous peer review process based on scientific merit, feasibility, innovation, and alignment with program goals. While specific application components are not detailed in the forecast, NIH opportunities generally require structured submissions via Grants.gov and associated systems. The timeline for this opportunity indicates that it is currently in the forecast stage. The estimated posting date is August 19, 2026, with an anticipated application due date of January 25, 2027. Awards are expected to be made around September 1, 2027, with project start dates aligned to that timeline. The program is expected to support Fiscal Year 2027 funding. No cost-sharing or matching requirement is specified, and funding amounts are not yet disclosed in the forecast notice. Overall, the ROBIN Centers program represents a significant federal investment in advancing cancer research through integrated, collaborative approaches. By focusing on the biological dynamics of radiation therapy, the program aims to accelerate translational discoveries that can inform future clinical trials and improve patient outcomes. The initiative also contributes to workforce development by fostering interdisciplinary collaboration and training within the radiation oncology research community.